By MATTHEW PERRONE, Associated Press

WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according to a government spokesperson.

Related Articles

Former acting Navy secretary: More military in academy faculty not a bad thing

White House demolition with dirt, drama, and DIY capitalism

Campus threats have spiked. But they’re tough cases to crack, expert says.

Amusement park lovers bid farewell to Six Flags America in Bowie

What’s on the ballot in the first general election since Donald Trump became president

Dr. George Tidmarsh , who was named to the FDA post in July, was placed on leave Friday after officials in the Department of Health and Human

See Full Page